R Pili
Overview
Explore the profile of R Pili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khan S, Mhaka A, Pili R, Isaacs J
Bioorg Med Chem Lett
. 2001 Mar;
11(4):451-2.
PMID: 11229745
A modified procedure for the synthesis of Linomide is described. The synthesized drug was characterized and assessed for its in vivo antiangiogenic activity. In a murine angiogenesis assay Linomide treatment...
12.
Pili R, Chang J, Muhlhauser J, Crystal R, Capogrossi M, Passaniti A
Int J Cancer
. 1997 Oct;
73(2):258-63.
PMID: 9335452
Gene transfer of angiogenic growth factors with replication-deficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate...
13.
Muhlhauser J, Merrill M, Pili R, Maeda H, Bacic M, Bewig B, et al.
Circ Res
. 1995 Dec;
77(6):1077-86.
PMID: 7586219
To evaluate the concept that localized delivery of angiogenic factors via virus-mediated gene transfer may be useful in the treatment of ischemic disorders, the replication-deficient adenovirus (Ad) vector AdCMV.VEGF165 (where...
14.
Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, et al.
Int J Cancer
. 1995 Nov;
63(5):673-9.
PMID: 7591284
Gene transfer techniques may provide efficient treatment for a variety of malignant neoplasms. A replication-deficient adenovirus (Ad) vector which carries the cDNA for wild-type p53 (AdCMV.p53) was tested for its...
15.
Muhlhauser J, Pili R, Merrill M, Maeda H, Passaniti A, Crystal R, et al.
Hum Gene Ther
. 1995 Nov;
6(11):1457-65.
PMID: 8573618
In vivo gene transfer of angiogenic growth factors represents a potential approach to the treatment of ischemic diseases. The present study examined the in vitro and in vivo effects of...
16.
Pili R, Chang J, Partis R, Mueller R, Chrest F, Passaniti A
Cancer Res
. 1995 Jul;
55(13):2920-6.
PMID: 7540952
The development of drugs that target the tumor neovasculature may hold promise in inhibiting tumor growth. Experiments in vivo with castanospermine, an inhibitor of the glucosidases that convert protein N-linked...
17.
Ziegelstein R, Corda S, Pili R, Passaniti A, Lefer D, Zweier J, et al.
Circulation
. 1994 Oct;
90(4):1899-907.
PMID: 7923678
Background: Increases in both leukocyte and endothelial cytosolic free [Ca2+] may be involved in intercellular adhesion by regulating the affinity of surface adhesion molecules or by facilitating transendothelial leukocyte migration....
18.
Pili R, Guo Y, Chang J, Nakanishi H, Martin G, Passaniti A
J Natl Cancer Inst
. 1994 Sep;
86(17):1303-14.
PMID: 7520508
Background: Cancer incidence increases with age, but the growth and spread of tumors is often slow and prolonged in the elderly. Transplantable murine tumors grow and spread less readily in...
19.
Ziegelstein R, Spurgeon H, Pili R, Passaniti A, Cheng L, Corda S, et al.
Circ Res
. 1994 Jan;
74(1):151-6.
PMID: 8261589
The presence of the ryanodine receptor was recently demonstrated in vascular and endocardial endothelium, but its function has not been established. We investigated whether functional ryanodine-sensitive Ca2+ stores are present...
20.
Guo Y, Pili R, Passaniti A
Prostate
. 1994 Jan;
24(1):1-10.
PMID: 7507237
We have examined the role of extracellular matrix (ECM), cell growth, and dihydrotestosterone on the expression of prostate-specific antigen (PSA) by human prostatic carcinoma cells LNCaP. ECM induced a transient...